Evidence map›Paper›PMID 12821472›Full record

ArticleAntimicrobial agents and chemotherapy2003

Detection of inhibition of bovine viral diarrhea virus by aromatic cationic molecules.

M Daniel Givens, Christine C Dykstra, Kenny V Brock, David A Stringfellow, Arvind Kumar, Chad E Stephens, Hakan Goker, David W Boykin

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Cycluridine: A novel antiviral effective against flaviviruses.Antiviral chemistry & chemotherapy · 2017
    Review
  3. Article
  4. Effect of treatment with a cationic antiviral compound on acute infection with bovine viral diarrhea virus.Canadian journal of veterinary research = Revue canadienne de recherche veterinaire · 2013
    Article
  5. Article
  6. Article
  7. The synthesis of dicationic extended bis-benzimidazoles.Molecules (Basel, Switzerland) · 2004
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

M Daniel GivensDepartment of Pathobiology, College of Veterinary Medicine, Auburn University, Auburn, Alabama 36849, USA. givenmd@vetmed.auburn.edu
Christine C Dykstra
Kenny V Brock
David A Stringfellow
Arvind Kumar
Chad E Stephens
Hakan Goker
David W Boykin

Funding

ANTI-VIRAL TREATMENT OF DEVELOPING BOVINE EMBRYOSK08AI001728 · NIAID · AUBURN UNIVERSITY AT AUBURN · PI GIVENS, MAURICE D · 2000 to 2002
$352k
NIAID NIH HHS AI-01728-01
6 · The paper itself

Abstract

Bovine viral diarrhea virus (BVDV) is an economically significant pathogen of cattle and a problematic contaminant in the laboratory. BVDV is often used as an in vitro model for hepatitis C virus during drug discovery efforts. Aromatic dicationic molecules have exhibited inhibitory activity against several RNA viruses. Thus, the purpose of this research was to develop and apply a method for screening the aromatic cationic compounds for in vitro cytotoxicity and activity against a noncytopathic strain of BVDV. The screening method evaluated the concentration of BVDV in medium and cell lysates after 72 h of cell culture in the presence of either a 25 or 5 microM concentration of the test compound. Five of 93 screened compounds were selected for further determination of inhibitory (90 and 50%) and cytotoxic (50 and 10%) concentration endpoints. The screening method identified compounds that exhibited inhibition of BVDV at nanomolar concentrations while exhibiting no cytotoxicity at 25 microM concentrations. The leading compounds require further investigation to determine their mechanism of action, in vivo activity, and specific activity against hepatitis C virus.

Indexed as

AnimalsAntiviral AgentsBenzamidinesCationsCattleDiarrhea Viruses, Bovine ViralFuransGuanidinesImidazolesRNA, ViralStructure-Activity RelationshipAntiviral AgentsBenzamidinesCationsfuramidineFuransfurimidazolineGuanidinesImidazolespafuramidineRNA, Viral

Identifiers

PMID12821472
PMCPMC161853

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.